These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6515901)

  • 21. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxic epidermal necrolysis caused by flurazepam?
    Loncar C; Franić T; Bilusić M
    Psychiatr Danub; 2005 Dec; 17(3-4):236-9. PubMed ID: 16392434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of Lyell's syndrome caused by carbamazepine].
    Urbanowski S; Gwieździński Z; Rybakowski J
    Wiad Lek; 1995; 48(1-12):154-6. PubMed ID: 9638230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic epidermal necrolysis caused by tetrazepam.
    Delesalle F; Carpentier O; Guatier S; Delaporte E
    Int J Dermatol; 2006 Apr; 45(4):480. PubMed ID: 16650186
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxic epidermal necrolysis associated with quinidine administration.
    Adornato MC
    N Y State Dent J; 2000 Mar; 66(3):38-40. PubMed ID: 10808726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor.
    Jarrett P; Rademaker M; Havill J; Pullon H
    Clin Exp Dermatol; 1997 May; 22(3):146-7. PubMed ID: 9425696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Lee HY; Pang SM; Thamotharampillai T
    J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633
    [No Abstract]   [Full Text] [Related]  

  • 28. Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients.
    Kashiwagi M; Aihara M; Takahashi Y; Yamazaki E; Yamane Y; Song Y; Muramatsu M; Ikezawa Z
    J Dermatol; 2008 Oct; 35(10):683-5. PubMed ID: 19017052
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hyperosmolarity and non-ketotic hyperglycemia].
    Veloso FT; Fraga J; Noronha R; Brandão F
    Acta Med Port; 1980; 2(4):285-93. PubMed ID: 7010924
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug-induced toxic epidermal necrolysis with involvement of the intestinal and respiratory tract. A case report].
    Jäckel R; Fuchs M; Raff T; Wiedemann B
    Anaesthesist; 2002 Oct; 51(10):815-9. PubMed ID: 12395172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Toxic epidermal necrolysis, a life-threatening skin disease].
    Brouwer KJ; Boxma H; Dokter J
    Ned Tijdschr Geneeskd; 1994 Sep; 138(36):1819-22. PubMed ID: 7935909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homeostasis. Part 4: fluid balance.
    Docherty B; Foudy C
    Nurs Times; 2006 Apr 25-May 1; 102(17):22-3. PubMed ID: 16700228
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hyperosmolality (author's transl)].
    Leeman M
    Rev Med Brux; 1980 Jun; 1(6):357-60. PubMed ID: 7466034
    [No Abstract]   [Full Text] [Related]  

  • 34. HLA-B*1502 allele associated with carbamazepine-induced epidermal necrolysis.
    Odueyungbo MA; Sheehan MP; Haggstrom AN
    Arch Dermatol; 2010 Dec; 146(12):1437-8. PubMed ID: 21173336
    [No Abstract]   [Full Text] [Related]  

  • 35. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vulval adenosis associated with toxic epidermal necrolysis.
    Noël JC; Buxant F; Fayt I; Bebusschere G; Parent D
    Br J Dermatol; 2005 Aug; 153(2):457-8. PubMed ID: 16086774
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bullous and necrotic manifestations in barbituric poisoning].
    Bureau Y; Barrière H; Litoux P; Bureau B
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(2):104-8. PubMed ID: 5128239
    [No Abstract]   [Full Text] [Related]  

  • 39. [Artificial nutrition of patients with toxic epidermal necrolysis (Lyell syndrome)].
    Kertai M; Dárdai E; Telkes M; Nébenführer L
    Orv Hetil; 1997 Oct; 138(41):2609-11. PubMed ID: 9411331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of fluid and electrolyte disorders in the neonate.
    Nash MA
    Clin Perinatol; 1981 Jun; 8(2):251-62. PubMed ID: 7273586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.